Published in Med J Aust on November 02, 1992
Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust (1993) 0.75
Gastric fundal polyps with cellular atypia in a patient using esomeprazole (Nexium). Dig Dis Sci (2005) 0.75
Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust (1992) 2.33
Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother (1983) 8.82
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology (2000) 5.40
Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest (1980) 5.11
Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med (1982) 5.07
The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69
The pharmacokinetics and tissue penetration of ofloxacin. J Antimicrob Chemother (1984) 4.15
Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut (2004) 3.85
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology (2000) 3.58
Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology (1988) 3.51
A new technique for continuous sphincter pressure measurement. Gastroenterology (1976) 3.44
The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol (1998) 3.04
Transient lower esophageal sphincter relaxation. Gastroenterology (1995) 2.91
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet (2001) 2.88
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother (1985) 2.85
Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrob Agents Chemother (1984) 2.83
Pharmacokinetics and tissue penetration of enoxacin. Antimicrob Agents Chemother (1984) 2.79
Pathogenesis of reflux esophagitis. Gastroenterology (1981) 2.58
Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology (1995) 2.53
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol (1998) 2.44
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11
Behavior and gastroesophageal reflux in the premature neonate. J Pediatr Gastroenterol Nutr (2000) 2.07
Hydatidiform mole in England and Wales 1973-83. Lancet (1986) 2.05
Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1990) 1.95
Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers. Am J Physiol (1988) 1.89
Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology (2000) 1.86
Manometric disorders in patients with suspected sphincter of Oddi dysfunction. Gastroenterology (1985) 1.75
Origin of spiral organisms in human gastric antrum. Lancet (1988) 1.72
Upper esophageal sphincter function during deglutition. Gastroenterology (1988) 1.71
Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut (1996) 1.71
Mechanisms responsible for gastroesophageal reflux in children. Gastroenterology (1997) 1.70
Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology (1986) 1.66
Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion? Aliment Pharmacol Ther (2000) 1.65
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology (1997) 1.62
Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther (2004) 1.61
Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther (2010) 1.59
Motor activity of the gastric antrum, pylorus, and duodenum under fasted conditions and after a liquid meal. Gastroenterology (1988) 1.57
Control of belching by the lower oesophageal sphincter. Gut (1990) 1.54
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br J Obstet Gynaecol (1986) 1.53
Upper esophageal sphincter function during belching. Gastroenterology (1986) 1.50
A comparison of transnasal and transoral endoscopy with small-diameter endoscopes in unsedated patients. Gastrointest Endosc (1999) 1.50
Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology (1988) 1.50
Abolition of gas reflux and transient lower esophageal sphincter relaxation by vagal blockade in the dog. Gastroenterology (1986) 1.49
Efficient utilization of echocardiography for the assessment of left ventricular systolic function. Am Heart J (2000) 1.46
Stimulation of pyloric motility by intraduodenal dextrose in normal subjects. Gut (1988) 1.44
Human duodenal phase III migrating motor complex activity is predominantly antegrade, as revealed by high-resolution manometry and colour pressure plots. Neurogastroenterol Motil (2002) 1.44
The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid. J Antimicrob Chemother (1984) 1.43
Interdigestive phasic contractions of the human lower esophageal sphincter. Gastroenterology (1983) 1.43
Effect of cisapride on secondary peristalsis in patients with gastroesophageal reflux disease. Am J Gastroenterol (1999) 1.40
The importance of the pylorus as a regulator of solid and liquid emptying from the stomach. J Gastroenterol Hepatol (1996) 1.40
Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid. Antimicrob Agents Chemother (1983) 1.40
Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumours. Br J Cancer (1983) 1.40
Manual-assisted cognitive-behaviour therapy (MACT): a randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm. Psychol Med (1999) 1.39
Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion. J Gastroenterol Hepatol (1991) 1.39
Pharyngeal (Zenker's) diverticulum is a disorder of upper esophageal sphincter opening. Gastroenterology (1992) 1.39
Motor events underlying gastro-oesophageal reflux in ambulant patients with reflux oesophagitis. Neurogastroenterol Motil (1996) 1.38
Response of canine lower esophageal sphincter to gastric distension. Am J Physiol (1990) 1.37
The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol (1989) 1.35
Effect of sleep, spontaneous gastroesophageal reflux, and a meal on upper esophageal sphincter pressure in normal human volunteers. Gastroenterology (1987) 1.34
Hyperglycaemia stimulates pyloric motility in normal subjects. Gut (1991) 1.34
Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux. Dig Dis Sci (1991) 1.29
Effect of atropine on esophageal motor function in humans. Am J Physiol (1981) 1.29
Influence of normal aging on oral-pharyngeal and upper esophageal sphincter function during swallowing. Am J Physiol (1995) 1.28
Relation of pyloric motility to pyloric opening and closure in healthy subjects. Gut (1992) 1.28
A prospective genetic study of complete and partial hydatidiform moles. Am J Obstet Gynecol (1991) 1.28
Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci (1994) 1.23
Serum-SP1-pregnancy-specific-beta-glycoprotein in choriocarcinoma and other neoplastic disease. Lancet (1978) 1.21
Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut (2002) 1.21
Pathophysiology of gastroesophageal reflux. Lower esophageal sphincter dysfunction in gastroesophageal reflux disease. Gastroenterol Clin North Am (1990) 1.19
Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther (1997) 1.18
Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects. Gastroenterology (1995) 1.18
Effect of intraduodenal fat on lower oesophageal sphincter function and gastro-oesophageal reflux. Gut (1997) 1.18
Relative contributions of "pressure pump" and "peristaltic pump" to gastric emptying. Am J Physiol Gastrointest Liver Physiol (2000) 1.17
Topography and measurement of pyloric pressure waves and tone in humans. Am J Physiol (1988) 1.17
Extrinsic and intrinsic neural control of pyloric sphincter pressure in the dog. J Physiol (1988) 1.14
Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol (1989) 1.14
Effect of gastro-oesophageal reflux on upper oesophageal sphincter motility in children. Gut (1993) 1.13
Recent views on the pathogenesis of gastro-oesophageal reflux disease. Baillieres Clin Gastroenterol (1987) 1.13
Human lower esophageal sphincter pressure response to increased intra-abdominal pressure. Am J Physiol (1990) 1.13
Impacts and patterns of disturbed gastrointestinal function in critically ill patients. Am J Gastroenterol (2000) 1.11
Esophageal body and lower esophageal sphincter function in healthy premature infants. Gastroenterology (1995) 1.10
Esophageal contractions induced by vagal stimulation in the opossum. Am J Physiol (1978) 1.10
Disordered gastric emptying: mechanical basis, assessment and treatment. Baillieres Clin Gastroenterol (1991) 1.09
Sphincter of Oddi motility disorders in patients with idiopathic recurrent pancreatitis. Br J Surg (1985) 1.09
HTLV-I among Northern Territory blood donors. Med J Aust (1993) 1.09
Mechanisms underlying the antireflux action of fundoplication. Gut (1993) 1.09
Relationships between spatial patterns of colonic pressure and individual movements of content. Am J Physiol Gastrointest Liver Physiol (2000) 1.08
Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet (1990) 1.08
Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. Br Med J (Clin Res Ed) (1984) 1.07
Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride. Gut (1994) 1.07
Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin. J Clin Invest (1987) 1.07
A method for continuous monitoring of upper esophageal sphincter pressure. Dig Dis Sci (1987) 1.05
Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists. Am J Physiol (1999) 1.05
Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood (1984) 1.05
Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme. Aliment Pharmacol Ther (2002) 1.05
Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole. Br J Obstet Gynaecol (1976) 1.05